4.835USD+6.97%Mkt Cap: 485.42M USDP/E: —Last update: 2026-06-01
The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The compa…
Industry Peers
Medical Care Facilities87.66BTRYP/E 15.5
82.76BUSDP/E 12.9
31.03BSEKP/E 36.2
19.97BEURP/E 13.2
16.19BSEKP/E 19.2
14.78BUSDP/E 8.9
12.32BUSDP/E 18.5
11.64BSEKP/E 17.0
Indicators:|
Key Statistics
Company
Market Cap485.42M USD
Enterprise Value544.05M USD
Revenue (TTM)545.76M USD
Gross Profit76.44M USD
Net Income (TTM)-60.61M USD
Revenue/Share5.537 USD
Last Price4.835 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees641
CountryUS
SectorHealthcare
IndustryMedical Care Facilities
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-29.31
PEG—
EV/EBITDA-21.00
EV/Revenue1.00
P/S0.86
P/B-29.50
EPS (TTM)-0.35
EPS (Forward)-0.16
52W Range
2.01598% of range4.880
52W High4.880 USD
52W Low2.015 USD
Profitability
Gross Margin15.20%
Oper. Margin-4.42%
EBITDA Margin-4.75%
Profit Margin-12.06%
ROE385.53%
ROA-36.81%
Growth
Revenue Growth41.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-24.59M USD
CapEx (TTM)3.20M USD
FCF Margin-2.81%
FCF Yield-3.15%
Net Debt74.63M USD
Net Debt/EBITDA-2.88
Balance Sheet
Debt/Equity-6.60
Current Ratio1.47
Quick Ratio1.13
Book Value/Sh-0.1590 USD
Cash/Share0.3030 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)7.000 USD
Target Range5.000 USD – 8.000 USD
# Analysts4
Ownership
Shares Out.99.98M
Float87.41M
Insiders18.16%
Institutions46.09%
Short Interest
Short Ratio4.2d
Short % Float7.44%
Short % Out.6.52%
Shares Short6.52M
Short (prev mo.)8.07M
Technical
SMA 503.655 (+32.3%)
SMA 2003.478 (+39.0%)
Beta0.36
S&P 52W Chg27.70%
Avg Vol (30d)1.50M
Avg Vol (10d)1.62M
Technical Indicators
RSI (14)67.7
MACD0.2805
MACD Signal0.2509
MACD Hist.+0.0296
BB Upper4.743 USD
BB Middle4.196 USD
BB Lower3.648 USD
BB Width26.08%
ATR (14)0.2537 USD
Vol Ratio (20d)0.40x